176 related articles for article (PubMed ID: 33081820)
1. High throughput single-cell detection of multiplex CRISPR-edited gene modifications.
Ten Hacken E; Clement K; Li S; Hernández-Sánchez M; Redd R; Wang S; Ruff D; Gruber M; Baranowski K; Jacob J; Flynn J; Jones KW; Neuberg D; Livak KJ; Pinello L; Wu CJ
Genome Biol; 2020 Oct; 21(1):266. PubMed ID: 33081820
[TBL] [Abstract][Full Text] [Related]
2. The genomes of precision edited cloned calves show no evidence for off-target events or increased de novo mutagenesis.
Jivanji S; Harland C; Cole S; Brophy B; Garrick D; Snell R; Littlejohn M; Laible G
BMC Genomics; 2021 Jun; 22(1):457. PubMed ID: 34139989
[TBL] [Abstract][Full Text] [Related]
3. The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia.
García-Tuñón I; Hernández-Sánchez M; Ordoñez JL; Alonso-Pérez V; Álamo-Quijada M; Benito R; Guerrero C; Hernández-Rivas JM; Sánchez-Martín M
Oncotarget; 2017 Apr; 8(16):26027-26040. PubMed ID: 28212528
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
[TBL] [Abstract][Full Text] [Related]
5. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
6. Efficient CRISPR/Cas9-mediated gene editing in Guangdong small-ear spotted pig cells using an optimized electrotransfection method.
Wei YY; Zhan QM; Zhu XX; Yan AF; Feng J; Liu L; Li JH; Tang DS
Biotechnol Lett; 2020 Nov; 42(11):2091-2109. PubMed ID: 32494996
[TBL] [Abstract][Full Text] [Related]
7. Highly Multiplexed Analysis of CRISPR Genome Editing Outcomes in Mammalian Cells.
Ishiguro S; Yachie N
Methods Mol Biol; 2021; 2312():193-223. PubMed ID: 34228292
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.
You H; Mayer JU; Johnston RL; Sivakumaran H; Ranasinghe S; Rivera V; Kondrashova O; Koufariotis LT; Du X; Driguez P; French JD; Waddell N; Duke MG; Ittiprasert W; Mann VH; Brindley PJ; Jones MK; McManus DP
FASEB J; 2021 Jan; 35(1):e21205. PubMed ID: 33337558
[TBL] [Abstract][Full Text] [Related]
9. Optimization of multiplexed CRISPR/Cas9 system for highly efficient genome editing in Setaria viridis.
Weiss T; Wang C; Kang X; Zhao H; Elena Gamo M; Starker CG; Crisp PA; Zhou P; Springer NM; Voytas DF; Zhang F
Plant J; 2020 Nov; 104(3):828-838. PubMed ID: 32786122
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice.
Weber J; Öllinger R; Friedrich M; Ehmer U; Barenboim M; Steiger K; Heid I; Mueller S; Maresch R; Engleitner T; Gross N; Geumann U; Fu B; Segler A; Yuan D; Lange S; Strong A; de la Rosa J; Esposito I; Liu P; Cadiñanos J; Vassiliou GS; Schmid RM; Schneider G; Unger K; Yang F; Braren R; Heikenwälder M; Varela I; Saur D; Bradley A; Rad R
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13982-7. PubMed ID: 26508638
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs.
Lee HJ; Kim HJ; Lee SJ
Genome Res; 2020 May; 30(5):768-775. PubMed ID: 32327447
[TBL] [Abstract][Full Text] [Related]
14. Mosaicism in CRISPR/Cas9-mediated genome editing.
Mehravar M; Shirazi A; Nazari M; Banan M
Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
[TBL] [Abstract][Full Text] [Related]
15. Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies.
Mehravar M; Roshandel E; Salimi M; Chegeni R; Gholizadeh M; Mohammadi MH; Hajifathali A
Immunol Lett; 2020 Oct; 226():71-82. PubMed ID: 32687855
[TBL] [Abstract][Full Text] [Related]
16. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
Qin W; Wang H
Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
18. Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
Ousterout DG; Kabadi AM; Thakore PI; Majoros WH; Reddy TE; Gersbach CA
Nat Commun; 2015 Feb; 6():6244. PubMed ID: 25692716
[TBL] [Abstract][Full Text] [Related]
19. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
